Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 2a,Condition 2b,Condition 3 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood triglyceride amount,,RS:0000280,F344.GK-(D1Arb42a-D1Rat90)/Swe,male,185 days,10,,CMO:0000360,serum triglyceride level,,,,191.15136,mg/dl,12.3894,39.1788,MMO:0000136,serum triglyceride analysis,tail vein,,"Vitros TRIG slides (Johnson & Johnson, Rochester, NY)",,,,fasting (between 6 and 7 hours),11474,fasting (between 6 and 7 hours),,,, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood triglyceride amount,,RS:0000305,F344/DuCrlCrlj,male,185 days,9,,CMO:0000360,serum triglyceride level,,,,203.5408,mg/dl,7.9646,23.8939,MMO:0000136,serum triglyceride analysis,tail vein,,"Vitros TRIG slides (Johnson & Johnson, Rochester, NY)",,,,fasting (between 6 and 7 hours),11476,fasting (between 6 and 7 hours),,,, 85,"Galli J, et al., Diabetes 1999 Dec;48(12):2463-70.",blood triglyceride amount,,RS:0000281,F344.GK-(D1Mgh10-D1Rat119)/Swe,male,185 days,10,,CMO:0000360,serum triglyceride level,,,,268.14288,mg/dl,14.1594,44.7758,MMO:0000136,serum triglyceride analysis,tail vein,,"Vitros TRIG slides (Johnson & Johnson, Rochester, NY)",,,,fasting (between 6 and 7 hours),11478,fasting (between 6 and 7 hours),,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000770,SHRSP/Izm,male,91 days,5,,CMO:0000360,serum triglyceride level,,,,57.5224,mg/dl,10.6195,23.746,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64856,fasting (0 null) (for 16 hours),,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000772,SHRSP.WKY-(Klk1-D1Rat116)/Izm,male,91 days,5,,CMO:0000360,serum triglyceride level,,,,42.47808,mg/dl,7.9646,17.8095,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64857,fasting (0 null) (for 16 hours),,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000771,WKY/Izm,male,91 days,5,,CMO:0000360,serum triglyceride level,,,,24.77888,mg/dl,2.6549,5.9365,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64858,fasting (0 null) (for 16 hours),,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000770,SHRSP/Izm,female,91 days,5,,CMO:0000360,serum triglyceride level,,,,50.44272,mg/dl,11.5045,25.7248,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64859,fasting (0 null) (for 16 hours),,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000772,SHRSP.WKY-(Klk1-D1Rat116)/Izm,female,91 days,5,,CMO:0000360,serum triglyceride level,,,,77.87648,mg/dl,11.5045,25.7248,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64860,fasting (0 null) (for 16 hours),,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",blood triglyceride amount,,RS:0000771,WKY/Izm,female,91 days,5,,CMO:0000360,serum triglyceride level,,,,40.70816,mg/dl,7.9646,17.8095,MMO:0000136,serum triglyceride analysis,,0,,,,,fasting (0 null) (for 16 hours),64861,fasting (0 null) (for 16 hours),,,, 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",blood triglyceride amount,,RS:0000744,SHR/FubRkb,not specified,168 days,10,,CMO:0000360,serum triglyceride level,,,,61.9472,mg/dl,3.5398,11.194,MMO:0000136,serum triglyceride analysis,,0.0,serum triglyceride analysis,,,,control condition,65384,control condition,,,, 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",blood triglyceride amount,,RS:0001373,MWF-Chr 6SHR/Rkb,not specified,168 days,19,,CMO:0000360,serum triglyceride level,,,,108.85008,mg/dl,0.885,3.8575,MMO:0000136,serum triglyceride analysis,,0.0,serum triglyceride analysis,,,,control condition,65385,control condition,,,, 117,"Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21",blood triglyceride amount,,RS:0000596,MWF/FubRkb,not specified,168 days,18,,CMO:0000360,serum triglyceride level,,,,95.57568,mg/dl,11.5045,48.8094,MMO:0000136,serum triglyceride analysis,,0.0,serum triglyceride analysis,,,,control condition,65386,control condition,,,, 71,"Asahina M, et al., J Lipid Res 2005 Aug 1",blood triglyceride amount,,RS:0000269,ExHC/Seac,male,28 days,7,,CMO:0000360,serum triglyceride level,,,,98,mg/dl,7.3,19.314,MMO:0000136,serum triglyceride analysis,,,"Wako Pure Chemicals, Tokyo, Japan",,,,control condition,11314,control condition,,,, 71,"Asahina M, et al., J Lipid Res 2005 Aug 1",blood triglyceride amount,,RS:0000430,BN/Seac,male,28 days,11,,CMO:0000360,serum triglyceride level,,,,108,mg/dl,5.9,19.5681,MMO:0000136,serum triglyceride analysis,,,"Wako Pure Chemicals, Tokyo, Japan",,,,control condition,13139,control condition,,,, 71,"Asahina M, et al., J Lipid Res 2005 Aug 1",blood triglyceride amount,,RS:0000269,ExHC/Seac,male,42 days,7,,CMO:0000360,serum triglyceride level,,,,216,mg/dl,15.5,41.0091,MMO:0000136,serum triglyceride analysis,,0.0,"Wako Pure Chemicals, Tokyo, Japan",,,,controlled cholesterol content diet (1 %) (for 14 days) and controlled olive oil content diet (10 %) (for 14 days),13143,controlled cholesterol content diet (1 %) (for 14 days),controlled olive oil content diet (10 %) (for 14 days),,, 71,"Asahina M, et al., J Lipid Res 2005 Aug 1",blood triglyceride amount,,RS:0000430,BN/Seac,male,42 days,11,,CMO:0000360,serum triglyceride level,,,,79,mg/dl,13.3,44.1111,MMO:0000136,serum triglyceride analysis,,,"Wako Pure Chemicals, Tokyo, Japan",,,,controlled cholesterol content diet (1 %) (for 14 days) and controlled olive oil content diet (10 %) (for 14 days),13146,controlled cholesterol content diet (1 %) (for 14 days),controlled olive oil content diet (10 %) (for 14 days),,, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood triglyceride amount,,RS:0000364,F344/NSlc,male,218 days,7,,CMO:0000360,serum triglyceride level,,,,108.4,mg/dl,14.5,38.3634,MMO:0000136,serum triglyceride analysis,,0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),13192,specific pathogen-free condition (for 210 days),,fasting (for 1 days),, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood triglyceride amount,,RS:0001734,F344.OLETF-(D7Mgh16-D7Mgh20)/Tj,male,218 days,7,,CMO:0000360,serum triglyceride level,,,,89.9,mg/dl,6.73,17.8059,MMO:0000136,serum triglyceride analysis,,0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),13193,specific pathogen-free condition (for 210 days),,fasting (for 1 days),, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood triglyceride amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,218 days,11,,CMO:0000360,serum triglyceride level,,,,113.5,mg/dl,4.81,15.953,MMO:0000136,serum triglyceride analysis,,0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),13194,specific pathogen-free condition (for 210 days),,fasting (for 1 days),, 311,"Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21.",blood triglyceride amount,,RS:0001303,F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj,male,218 days,11,,CMO:0000360,serum triglyceride level,,,,111.7,mg/dl,8.83,29.2858,MMO:0000136,serum triglyceride analysis,,0.0,"Wako Pure Chemicals, Tokyo, Japan",,,,specific pathogen-free condition (for 210 days) then fasting (for 1 days),13195,specific pathogen-free condition (for 210 days),,fasting (for 1 days),, 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",blood triglyceride amount,,RS:0000746,SHR/Izm,male,98 days,10,,CMO:0000360,serum triglyceride level,,,,10.5,mg/dl,0.6641,2.1,MMO:0000136,serum triglyceride analysis,,,,,,,controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then fasting (for 16 hours),12448,controlled fat content diet (5 %) (for 70 days),controlled potassium content diet (0.75 %) (for 70 days),fasting (for 16 hours),, 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",blood triglyceride amount,,RS:0000746,SHR/Izm,male,113 days,10,,CMO:0000360,serum triglyceride level,,,,23.8,mg/dl,3.8264,12.1,MMO:0000136,serum triglyceride analysis,,,,,,,controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours),12478,controlled fat content diet (5 %) (for 70 days),controlled potassium content diet (0.75 %) (for 70 days),controlled fat content diet (26 %) (for 14 days),controlled potassium content diet (0.44 %) (for 14 days),fasting (for 16 hours) 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",blood triglyceride amount,,RS:0000771,WKY/Izm,male,98 days,10,,CMO:0000360,serum triglyceride level,,,,11,mg/dl,1.0752,3.4,MMO:0000136,serum triglyceride analysis,,,,,,,controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then fasting (for 16 hours),12499,controlled fat content diet (5 %) (for 70 days),controlled potassium content diet (0.75 %) (for 70 days),fasting (for 16 hours),, 263,"Watanabe T, et al., Biochem Biophys Res Commun 2005 Apr 15;329(3):879-87.",blood triglyceride amount,,RS:0000771,WKY/Izm,male,113 days,10,,CMO:0000360,serum triglyceride level,,,,15,mg/dl,1.8025,5.7,MMO:0000136,serum triglyceride analysis,,,,,,,controlled fat content diet (5 %) (for 70 days) and controlled potassium content diet (0.75 %) (for 70 days) then controlled fat content diet (26 %) (for 14 days) and controlled potassium content diet (0.44 %) (for 14 days) then fasting (for 16 hours),12508,controlled fat content diet (5 %) (for 70 days),controlled potassium content diet (0.75 %) (for 70 days),controlled fat content diet (26 %) (for 14 days),controlled potassium content diet (0.44 %) (for 14 days),fasting (for 16 hours) 248,"Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44.",blood triglyceride amount,,RS:0000284,OLETF,male,246 days,23,,CMO:0000360,serum triglyceride level,,,,218.77,mg/dl,13.4742,64.62,MMO:0000136,serum triglyceride analysis,carotid artery,,"Triglyceride E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan",,,,fasting (for 18 hours),12359,fasting (for 18 hours),,,, 248,"Ogino T, et al., Mamm Genome 2003 Dec;14(12):839-44.",blood triglyceride amount,,RS:0000313,F344/NRrrc,male,246 days,21,,CMO:0000360,serum triglyceride level,,,,131.8,mg/dl,4.5215,20.72,MMO:0000136,serum triglyceride analysis,carotid artery,,"Triglyceride E-test Wako, Wako Pure Chemical Industries, Ltd, Osaka, Japan",,,,fasting (for 18 hours),12376,fasting (for 18 hours),,,, 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood triglyceride amount,,RS:0000364,F344/NSlc,male,217 days,9,,CMO:0000360,serum triglyceride level,,,,122.4,mg/dl,25.3,75.9,MMO:0000136,serum triglyceride analysis,,0,,,,,control condition,66182,control condition,,,, 716,"Kose H, et al., Exp Anim. 2008 Apr;57(2):135-8.",blood triglyceride amount,,RS:0000296,F344.OLETF-(D8Rat58-D8Mgh17)/Tj,male,217 days,20,,CMO:0000360,serum triglyceride level,,,,167.8,mg/dl,15.3,68.4237,MMO:0000136,serum triglyceride analysis,,0,,,,,control condition,66183,control condition,,,, 834,"Garrett MR, et al., Physiol Genomics. 2007 May 15;.",blood triglyceride amount,,RS:0000924,SS/JrTol,male,140 days,6,,CMO:0000360,serum triglyceride level,,,,106.1,mg/dl,8.5,20.8207,MMO:0000136,serum triglyceride analysis,,0.0,,,,,control condition (for 140 days),67984,control condition (for 140 days),,,, 834,"Garrett MR, et al., Physiol Genomics. 2007 May 15;.",blood triglyceride amount,,RS:0002406,SHR/NHsdMco,male,140 days,6,,CMO:0000360,serum triglyceride level,,,,63,mg/dl,7.5,18.3712,MMO:0000136,serum triglyceride analysis,,0.0,,,,,control condition (for 140 days),67985,control condition (for 140 days),,,, 834,"Garrett MR, et al., Physiol Genomics. 2007 May 15;.",blood triglyceride amount,,RS:0001559,SS.SHR-(D2Rat61-D2Mco18)/Mco,male,140 days,6,,CMO:0000360,serum triglyceride level,,,,90.9,mg/dl,7.5,18.3712,MMO:0000136,serum triglyceride analysis,,0.0,,,,,control condition (for 140 days),67986,control condition (for 140 days),,,, 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",blood triglyceride amount,,RS:0000364,F344/NSlc,male,175 days to 168 days,7,,CMO:0000360,serum triglyceride level,,,,130.17,mg/dl,15.88,42.0145,MMO:0000136,serum triglyceride analysis,,0.0,"TG-E test kits, Wako Chem. Ltd. Osaka, Japan",,,,control condition,97750,control condition,,,, 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",blood triglyceride amount,,RS:0000289,F344.OLETF-(D14Rat23-D14Rat12)/Tj,male,175 days to 168 days,7,,CMO:0000360,serum triglyceride level,,,,80.54,mg/dl,8.04,21.2718,MMO:0000136,serum triglyceride analysis,,0.0,"TG-E test kits, Wako Chem. Ltd. Osaka, Japan",,,,control condition,97751,control condition,,,, 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",blood triglyceride amount,,RS:0001991,F344.ZUC-Leprfa/Tj,male,175 days to 168 days,10,,CMO:0000360,serum triglyceride level,,,,2342.86,mg/dl,269.19,851.2535,MMO:0000136,serum triglyceride analysis,,0.0,"TG-E test kits, Wako Chem. Ltd. Osaka, Japan",,,,control condition,97752,control condition,,,, 1918,"Sasaki D, et al., Mamm Genome. 2015 Dec;26(11-12):619-29. doi: 10.1007/s00335-015-9597-4. Epub 2015 Aug 22.",blood triglyceride amount,,RS:0004089,"F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj",male,175 days to 168 days,10,,CMO:0000360,serum triglyceride level,,,,1240.6,mg/dl,209.56,662.6869,MMO:0000136,serum triglyceride analysis,,0.0,"TG-E test kits, Wako Chem. Ltd. Osaka, Japan",,,,control condition,97753,control condition,,,, 2641,"Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331.",blood triglyceride amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,91 days,8,,CMO:0000360,serum triglyceride level,,,,54.5,mg/dl,9.5,26.8701,MMO:0000136,serum triglyceride analysis,,0.0,,,,,control condition,101849,control condition,,,, 2641,"Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331.",blood triglyceride amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,91 days,10,,CMO:0000360,serum triglyceride level,,,,87,mg/dl,4.08,12.9021,MMO:0000136,serum triglyceride analysis,,0.0,,,,,everolimus (0.83 mg/kg/d) (for 28 days),101850,everolimus (0.83 mg/kg/d) (for 28 days),,,, 2641,"Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331.",blood triglyceride amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,91 days,7,,CMO:0000360,serum triglyceride level,,,,1885.5,mg/dl,325.31,860.6894,MMO:0000136,serum triglyceride analysis,,0.0,,,,,control condition,101851,control condition,,,, 2641,"Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331.",blood triglyceride amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,91 days,12,,CMO:0000360,serum triglyceride level,,,,1251.33,mg/dl,276.6,958.1705,MMO:0000136,serum triglyceride analysis,,0.0,,,,,everolimus (0.83 mg/kg/d) (for 28 days),101852,everolimus (0.83 mg/kg/d) (for 28 days),,,, 2644,"Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4.",blood triglyceride amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,91 days,6,,CMO:0000360,serum triglyceride level,,,,2196.13,mg/dl,204.52,500.9696,MMO:0000136,serum triglyceride analysis,,0.0,,,,,vehicle control condition (0.5 %) (for 28 days),101950,vehicle control condition (0.5 %) (for 28 days),,,, 2644,"Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4.",blood triglyceride amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,91 days,7,,CMO:0000360,serum triglyceride level,,,,1190,mg/dl,324.22,857.8055,MMO:0000136,serum triglyceride analysis,,0.0,,,,,Atorvastatin (6 mg/kg/d) (for 28 days),101951,Atorvastatin (6 mg/kg/d) (for 28 days),,,, 2644,"Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4.",blood triglyceride amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,91 days,7,,CMO:0000360,serum triglyceride level,,,,980.67,mg/dl,302.75,801.0012,MMO:0000136,serum triglyceride analysis,,0.0,,,,,Atorvastatin (20 mg/kg/d) (for 28 days),101952,Atorvastatin (20 mg/kg/d) (for 28 days),,,, 2318,"Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10.",blood triglyceride amount,,RS:0000342,FHH/EurMcwi,male,56 days,6,,CMO:0000360,serum triglyceride level,,,,32,mg/dl,1.4,3.4293,MMO:0000136,serum triglyceride analysis,,0.0,,,,,control condition,99507,control condition,,,, 2318,"Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10.",blood triglyceride amount,,RS:0001132,FHH-Nr4a1m1Mcwi,male,56 days,6,,CMO:0000360,serum triglyceride level,,,,30,mg/dl,3.0,7.3485,MMO:0000136,serum triglyceride analysis,,0.0,,,,,control condition,99508,control condition,,,, 2318,"Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10.",blood triglyceride amount,,RS:0000342,FHH/EurMcwi,male,112 days,6,,CMO:0000360,serum triglyceride level,,,,37,mg/dl,5.3,12.9823,MMO:0000136,serum triglyceride analysis,,0.0,,,,,control condition,99509,control condition,,,, 2318,"Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10.",blood triglyceride amount,,RS:0001132,FHH-Nr4a1m1Mcwi,male,56 days,6,,CMO:0000360,serum triglyceride level,,,,82,mg/dl,12.6,30.8636,MMO:0000136,serum triglyceride analysis,,0.0,,,,,control condition,99510,control condition,,,, 2318,"Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10.",blood triglyceride amount,,RS:0000342,FHH/EurMcwi,male,112 days,6,,CMO:0000360,serum triglyceride level,,,,50,mg/dl,4.4,10.7778,MMO:0000136,serum triglyceride analysis,,0.0,,,,,control condition,99511,control condition,,,, 2318,"Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10.",blood triglyceride amount,,RS:0001132,FHH-Nr4a1m1Mcwi,male,56 days,6,,CMO:0000360,serum triglyceride level,,,,192,mg/dl,43.3,106.0629,MMO:0000136,serum triglyceride analysis,,0.0,,,,,control condition,99512,control condition,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",blood triglyceride amount,,RS:0000742,WKY,male,0 days,10,,CMO:0000360,serum triglyceride level,,,,61,mg/dl,5.0,15.8114,MMO:0000136,serum triglyceride analysis,,0.0,,,,,0.9% sodium chloride solution (3 ml) ,100409,0.9% sodium chloride solution (3 ml) ,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",blood triglyceride amount,,RS:0000742,WKY,male,0 days,11,,CMO:0000360,serum triglyceride level,,,,231,mg/dl,25.0,82.9156,MMO:0000136,serum triglyceride analysis,,0.0,,PA IV 50mg/kg,19,days,puromycin aminonucleoside (50 mg/kg) ,100410,puromycin aminonucleoside (50 mg/kg) ,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",blood triglyceride amount,,RS:0000742,WKY,male,0 days,10,,CMO:0000360,serum triglyceride level,,,,240,mg/dl,19.0,60.0833,MMO:0000136,serum triglyceride analysis,,0.0,,PA IV 50mg/kg,19,days,controlled enalapril content drinking water (50 mg/l) (for 26 days) then puromycin aminonucleoside (50 mg/kg) ,100411,controlled enalapril content drinking water (50 mg/l) (for 26 days),,puromycin aminonucleoside (50 mg/kg) ,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",blood triglyceride amount,,RS:0000742,WKY,male,0 days,11,,CMO:0000360,serum triglyceride level,,,,55,mg/dl,6.0,19.8997,MMO:0000136,serum triglyceride analysis,,0.0,,,,,0.9% sodium chloride solution (3 ml) ,100412,0.9% sodium chloride solution (3 ml) ,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",blood triglyceride amount,,RS:0000742,WKY,male,0 days,12,,CMO:0000360,serum triglyceride level,,,,73,mg/dl,5.0,17.3205,MMO:0000136,serum triglyceride analysis,,0.0,,PA IV 50mg/kg,,,puromycin aminonucleoside (50 mg/kg) ,100413,puromycin aminonucleoside (50 mg/kg) ,,,, 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",blood triglyceride amount,,RS:0000742,WKY,male,0 days,12,,CMO:0000360,serum triglyceride level,,,,72,mg/dl,9.0,31.1769,MMO:0000136,serum triglyceride analysis,,0.0,,PA IV 50mg/kg,,,controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days) then puromycin aminonucleoside (50 mg/kg) ,100414,controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days),,puromycin aminonucleoside (50 mg/kg) ,, 1978,"Kotoh J, et al., J Vet Med Sci. 2016 Aug 11.",blood triglyceride amount,,RS:0001991,F344.ZUC-Leprfa/Tj,male,175 days,7,,CMO:0000360,serum triglyceride level,,,,2420.6,mg/dl,316.29,836.8247,MMO:0000136,serum triglyceride analysis,,0.0,TG-E test kit (Wako Chem. LTD),,,,control condition,98078,control condition,,,, 1978,"Kotoh J, et al., J Vet Med Sci. 2016 Aug 11.",blood triglyceride amount,,RS:0004218,"F344.ZUC-(Leprfa),OLETF-(D5Rat166-D5Rat90)/Tj",male,175 days,5,,CMO:0000360,serum triglyceride level,,,,1851.46,mg/dl,150.35,336.1928,MMO:0000136,serum triglyceride analysis,,0.0,TG-E test kit (Wako Chem. LTD),,,,control condition,98079,control condition,,,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood triglyceride amount,,RS:0004409,Jcl:WI,male,52 days,6,,CMO:0000360,serum triglyceride level,,,,75.06,mg/dl,6.98,17.0974,MMO:0000136,serum triglyceride analysis,,0.0,,,,,control condition,103958,control condition,,,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood triglyceride amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0000360,serum triglyceride level,,,,114.12,mg/dl,14.21,34.8072,MMO:0000136,serum triglyceride analysis,,0.0,,,,,control condition,103959,control condition,,,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood triglyceride amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0000360,serum triglyceride level,,,,56.48,mg/dl,5.56,13.6192,MMO:0000136,serum triglyceride analysis,,0.0,,,,,controlled hesperidin content diet (1 %) (for 28 days),103960,controlled hesperidin content diet (1 %) (for 28 days),,,, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood triglyceride amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0000360,serum triglyceride level,,,,33.78,mg/dl,2.83,6.9321,MMO:0000136,serum triglyceride analysis,,0.0,,,,,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days),103961,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days),,,, 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood triglyceride amount,,RS:0004552,SS.ZUC-Leprfa+/+/Slc,male,126 days,6,,CMO:0000360,serum triglyceride level,,,,102.25,mg/dl,25.98,63.6377,MMO:0000136,serum triglyceride analysis,,0.0,,,,,fasting (for 16 hours),101917,fasting (for 16 hours),,,, 2642,"Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1.",blood triglyceride amount,,RS:0004550,SS.ZUC-Leprfa-/-/Slc,male,126 days,7,,CMO:0000360,serum triglyceride level,,,,1559.93,mg/dl,353.89,936.3049,MMO:0000136,serum triglyceride analysis,,0.0,,,,,fasting (for 16 hours),101918,fasting (for 16 hours),,,,